Pattern of hepatitis B and C infection among gravid women and their newborns in a tertiary care infirmary in India


  • Sheeba Marwah Department of Obstetrics & Gynecology, VMMC and Safdarjung Hospital, New Delhi, India
  • Ritin Mohindra Department of Internal Medicine, VMMC and Safdarjung Hospital, New Delhi, India
  • Sushmita Sharma Department of Obstetrics & Gynecology, Gian Sagar Medical College & hospital, Patiala, Punjab, India
  • Praveen V. Mohan Department of Obstetrics and Gynecology, Institute of Medical Sciences, Mullana, Ambala, India



Hepatitis, Hepatitis B antigen, Anti-hepatitis C antibody, Pregnancy outcomes, Sero-prevalance, Risk factors


Background: The objective is to determine the prevalence of the hepatitis B and C virus among pregnant women, to assess impact of maternal hepatitis B virus (HBV) or hepatitis C virus (HCV) carrier status on pregnancy outcomes and to gauge the risk factors associated with them. Antenatal clinic attenders and women undergoing termination of pregnancy over three years.

Methods: The study was conducted in Gian Sagar Medical College & Hospital, Patiala, Punjab, India. Hepatitis B antigen and Hepatitis C virus antibody testing of sera from specimens sent to the hospital laboratory for routine serological testing. The results were then linked to risk information, obstetric complications and pregnancy outcome.

Results: Overall HBsAg and anti-hepatitis C antibody prevalence was 1.2% (33/2031). Increased risk of transmission was associated with sexually transmitted diseases and previous surgical procedures. High rates of preterm labor pains, CD (27.27%), and non-reassuring fetal heart rate patterns and meconium stained liquor were found in the seropositive patients.

Conclusions: Maternal hepatitis B and C carrier status is an eminent risk factor for adverse pregnancy outcome.



Rabiu KA, Akinola OI, Adewunmi AA, Omololu OM, Ojo TO. Risk factors for hepatitis B virus infection among pregnant women in Lagos, Nigeria. Acta Obstetricia et Gynecologica. 2010; 89:1024-28.

World Health Organization. Hepatitis B. Fact sheet no. 204; July 2012. Accessed on 3 November 2015.

Cheung KW, Seto MTY, Wong SF. Towards complete eradication of hepatitis B infection from perinatal transmission: review of the mechanisms of in utero infection and the use of antiviral treatment during pregnancy. European J Obstet Gynecol Reprod Biol. 2013;169:17-23.

Hou J, Liu Z, Gu F. Epidemiology and prevention of hepatitis B virus infection. Int J Med Sci. 2005;2:50–7.

Global surveillance and control of hepatitis C. Report of a WHO Consultation organized in collaboration with the Viral Hepatitis Prevention Board, Antwerp, Belgium. J Viral Hepat. 1999;6:35-47.

Alter MJ, Kruszon-Moran D, Nainan OVMcQuillan GM, Gao F, Moyer LA et al. The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. N England J Med. 1999;341:556-62.

Martha W.F. Rac, Jeanne S. Sheffield. Prevention and management of viral hepatitis in pregnancy. Obstet Gynecol Clin N Am. 2014;41:573-92.

Lok AS. Chronic hepatitis B. N Engl J Med. 2002;346:1682-3.

Steven CE, Neurath RA, Beasley P, Szmuness W. HBeAg and anti-HBe detection by radioimmunoassay-correlation with vertical transmission of HBV in Taiwan. J Med Virol. 1979;3:237-41.

Wonke B, Hoffbrand AV, Brown D, Dusheiko G. Antibody to hepatitis B virus in multiply transfused patients with thalassaemia major. J Clin Path. 1990;43:638-40.

Murad EA, Babiker SM, Gasim GI, Rayis DA, Adam I. Epidemiology of hepatitis B and hepatitis C virus infections in pregnant women in Yemen. BMC Preg Childbirth. 2013;13:127.

Elsheikh RM, Daak AA, Elsheikh MA, Karsany MS, Adam I: Hepatitis B virus and hepatitis C virus in pregnant Sudanese women. Virol J. 2007;4:104.

Dwivedi M, Misra SP, Misra V, Pandey A, Pant S, Singh R et al. Seroprevalence of hepatitis B infection during pregnancy and risk of perinatal transmission. Indian J Gastroenterol. 2011;30(2):66-71.

Ndjomou J, Kupfer B, Kochan B, Zekeng L, Kaptue L, Matz B. Hepatitis C virus infection and genotypes among human immunodeficiency virus high risk groups in Cameroon. J Med Virol. 2002;66:179-86.

Kumara A, Sharma KA, Gupta RK, Karb P, Murthy NS. Hepatitis C virus infection during pregnancy in North India. Intern J Gynecol Obstet. 2005;88:55-6.

Altinbas S, Erdogan M, Danişman N. The seroprevalences of HBs Ag and anti-HCV in pregnant women in Ankara. Arch Gynecol Obstet. 2010;281:371.

Safir A, Levy A, Sikuler E, Sheiner E. Maternal hepatitis B virus or hepatitis C virus carrier status as an independent risk factor for adverse perinatal outcome. Liver Intern. 2010;2010:765-80.

Makuwa M, Caron M, Souquière S, Malonga-Mouelet G, Mahé A, Kazanji M. Prevalence and genetic diversity of hepatitis B and delta viruses in pregnant women in Gabon: molecular evidence that hepatitis delta virus clade 8 originates from and is endemic in central Africa. J Clin Microbiol. 2008;46:754-6.

Zahran KM, Badary MS, Agban MN, Nafesa HR, Aziz A. Pattern of hepatitis virus infection among pregnant women and their newborns at the Women's Health Center of Assiut University, Upper Egypt. Intern J Gynecol Obstet. 2010;111:171-4.

Alrowaily MA, Abolfotouh MA, Ferwanah MS. Hepatitis B virus sero-prevalence among pregnant females in Saudi Arabia. Saudi J Gastroenterol. 2008;14:70-2.

Bertolini DA, Pinho JRR, Saraceni CP, Moreira RC, Granato CFH, Carrilho FJ. Prevalence of serological markers of hepatitis B virus in pregnant women from Paraná State, Brazil. Braz J Med Biol Res. 2006;39:1083-90.






Original Research Articles